Comparing N-acetylcysteine and 4-methylpyrazole as antidotes for acetaminophen overdose

[1]  B. Rumack,et al.  Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series , 2021, Clinical toxicology.

[2]  H. Jaeschke,et al.  Delayed Administration of N-Acetylcysteine Blunts Recovery After an Acetaminophen Overdose Unlike 4-Methylpyrazole , 2021, Archives of Toxicology.

[3]  H. Jaeschke,et al.  Oxidant Stress and Acetaminophen Hepatotoxicity: Mechanism-Based Drug Development. , 2021, Antioxidants & redox signaling.

[4]  K. Lotfy,et al.  Massive acetaminophen overdose with metabolic acidosis refractory to N-acetylcysteine, fomepizole, and renal replacement therapy , 2021, Toxicology reports.

[5]  H. Jaeschke,et al.  Impaired protein adduct removal following repeat administration of subtoxic doses of acetaminophen enhances liver injury in fed mice , 2021, Archives of Toxicology.

[6]  H. Jaeschke,et al.  Mitochondrial Protein Adduct and Superoxide Generation are Prerequisites for Early Activation of c-Jun N-terminal Kinase within the Cytosol after an Acetaminophen Overdose in Mice. , 2020, Toxicology letters.

[7]  T. Kohno,et al.  Analgesic Effect of Acetaminophen: A Review of Known and Novel Mechanisms of Action , 2020, Frontiers in Pharmacology.

[8]  H. Jaeschke,et al.  4-methylpyrazole protects against acetaminophen-induced acute kidney injury. , 2020, Toxicology and applied pharmacology.

[9]  W. E. Freeman,et al.  Metabolic and mitochondrial treatments for severe paracetamol poisoning: a systematic review , 2020, Clinical toxicology.

[10]  B. Mégarbane,et al.  Analysis of fomepizole safety based on a 16-year post-marketing experience in France , 2020, Clinical toxicology.

[11]  M. Christensen,et al.  Two-bag intravenous N-acetylcysteine, antihistamine pretreatment and high plasma paracetamol levels are associated with a lower incidence of anaphylactoid reactions to N-acetylcysteine , 2020, Clinical toxicology.

[12]  C. Murphy,et al.  Fomepizole as an adjunctive treatment in severe acetaminophen ingestions: a case series , 2020, Clinical toxicology.

[13]  H. Jaeschke,et al.  Novel Therapeutic Approaches against Acetaminophen-induced Liver Injury and Acute Liver Failure. , 2020, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  A. Scalzo,et al.  Use of fomepizole as an adjunct in the treatment of acetaminophen overdose: a case series , 2020 .

[15]  R. Brigelius-Flohé,et al.  Regulatory phenomena in the glutathione peroxidase superfamily. , 2019, Antioxidants & redox signaling.

[16]  H. Jaeschke,et al.  The Effect of 4-Methylpyrazole on Oxidative Metabolism of Acetaminophen in Human Volunteers , 2019, Journal of Medical Toxicology.

[17]  H. Jaeschke,et al.  Emerging and established modes of cell death during acetaminophen-induced liver injury , 2019, Archives of Toxicology.

[18]  H. Jaeschke,et al.  Delayed Treatment With 4-Methylpyrazole Protects Against Acetaminophen Hepatotoxicity in Mice by Inhibition of c-Jun n-Terminal Kinase. , 2019, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  H. Jaeschke,et al.  Acetaminophen Hepatotoxicity , 2019, Seminars in Liver Disease.

[20]  R. Hendrickson.  What is the most appropriate dose of N-acetylcysteine after massive acetaminophen overdose? , 2019, Clinical toxicology.

[21]  B. Turna,et al.  Inter-individual and inter-organ variability in the bioactivation of paracetamol by human liver and kidney tissues. , 2018, Environmental toxicology and pharmacology.

[22]  H. Jaeschke,et al.  4-Methylpyrazole protects against acetaminophen hepatotoxicity in mice and in primary human hepatocytes , 2018, Human & experimental toxicology.

[23]  Mitchell R. McGill,et al.  Induction of mitochondrial biogenesis protects against acetaminophen hepatotoxicity. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  N. Buckley,et al.  Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2) , 2017, Clinical toxicology.

[25]  N. Kaplowitz,et al.  The role of MAP2 kinases and p38 kinase in acute murine liver injury models , 2017, Cell Death and Disease.

[26]  P. Dargan,et al.  Outcomes from massive paracetamol overdose: a retrospective observational study , 2017, British journal of clinical pharmacology.

[27]  H. Jaeschke,et al.  Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential , 2016, Redox biology.

[28]  Mitchell R. McGill,et al.  Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice. , 2016, Journal of hepatology.

[29]  N. Kaplowitz,et al.  c‐Jun N‐terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)‐dependent pathway leading to inactivation of intramitochondrial Src , 2016, Hepatology.

[30]  J. Dear,et al.  Plasma paracetamol concentration at hospital presentation has a dose-dependent relationship with liver injury despite prompt treatment with intravenous acetylcysteine , 2016, Clinical toxicology.

[31]  L. Yip,et al.  Potential adjunct treatment for high-risk acetaminophen overdose , 2016, Clinical toxicology.

[32]  Mitchell R. McGill,et al.  Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes. , 2015, Toxicology and applied pharmacology.

[33]  H. Jaeschke,et al.  Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury. , 2015, Toxicology and applied pharmacology.

[34]  V. Srinivasan,et al.  An accidental overdose of N-acetylcysteine during treatment for acetaminophen toxicity , 2015, Clinical toxicology.

[35]  William M. Lee,et al.  Risk factors and outcomes of acute kidney injury in patients with acute liver failure. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  Mitchell R. McGill,et al.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. , 2014, Toxicology and applied pharmacology.

[37]  B. Rumack,et al.  A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning , 2014, Clinical toxicology.

[38]  R. Ben-Joseph,et al.  A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States , 2014, Expert review of clinical pharmacology.

[39]  Takao Iwawaki,et al.  CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. , 2013, Journal of hepatology.

[40]  Hartmut Jaeschke,et al.  Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. , 2013, Toxicology and applied pharmacology.

[41]  Mitchell R. McGill,et al.  Metabolism and Disposition of Acetaminophen: Recent Advances in Relation to Hepatotoxicity and Diagnosis , 2013, Pharmaceutical Research.

[42]  K. Heard,et al.  Acetylcysteine therapy for acetaminophen poisoning. , 2012, Current pharmaceutical biotechnology.

[43]  B. Rumack,et al.  Acetaminophen and acetylcysteine dose and duration: Past, present and future , 2012, Clinical toxicology.

[44]  Mitchell R. McGill,et al.  Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: Lessons learned from acetaminophen hepatotoxicity , 2012, Drug metabolism reviews.

[45]  H. Jaeschke,et al.  Activation of autophagy protects against acetaminophen‐induced hepatotoxicity , 2012, Hepatology.

[46]  B. Hendry,et al.  Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[47]  K. Heard,et al.  Massive acetylcysteine overdose associated with cerebral edema and seizures , 2011, Clinical toxicology.

[48]  Hartmut Jaeschke,et al.  HepaRG cells: A human model to study mechanisms of acetaminophen hepatotoxicity , 2011, Hepatology.

[49]  S. Doyon,et al.  Intravenous acetylcysteine for the treatment of acetaminophen overdose , 2011, Expert opinion on pharmacotherapy.

[50]  E. Lavonas,et al.  Therapeutic Acetaminophen Is Not Associated With Liver Injury in Children: A Systematic Review , 2010, Pediatrics.

[51]  K. McMartin.  Antidotes for Alcohol and Glycol Toxicity: Translating Mechanisms Into Treatments , 2010, Clinical pharmacology and therapeutics.

[52]  D. Morgan,et al.  Validation of the American Association of Poison Control Centers out of hospital guideline for pediatric diphenhydramine ingestions , 2010, Clinical toxicology.

[53]  H. Jaeschke,et al.  c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity. , 2010, Toxicology and applied pharmacology.

[54]  C. Zwingmann,et al.  Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N‐acetylcysteine , 2010, Hepatology.

[55]  I. Stiell,et al.  Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. , 2009, Annals of emergency medicine.

[56]  M. Fink,et al.  Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity , 2009, Critical care.

[57]  A. Levy,et al.  Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. , 2009, Annals of emergency medicine.

[58]  M. Karin,et al.  Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. , 2008, Gastroenterology.

[59]  Sushma Sharma,et al.  Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose , 2008, Clinical toxicology.

[60]  H. Jaeschke,et al.  Mitochondrial Bax Translocation Accelerates DNA Fragmentation and Cell Necrosis in a Murine Model of Acetaminophen Hepatotoxicity , 2008, Journal of Pharmacology and Experimental Therapeutics.

[61]  B. Rumack,et al.  Patient-tailored acetylcysteine administration. , 2007, Annals of emergency medicine.

[62]  R. Dart,et al.  Does Therapeutic Use of Acetaminophen Cause Acute Liver Failure? , 2007, Pharmacotherapy.

[63]  H. Jaeschke,et al.  Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[64]  J. Schweinle,et al.  Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. , 2006, Clinical therapeutics.

[65]  H. Jaeschke,et al.  Peroxynitrite-Induced Mitochondrial and Endonuclease-Mediated Nuclear DNA Damage in Acetaminophen Hepatotoxicity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[66]  Steven D. Cohen,et al.  Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity in CD-1 mice: I. Enhancement of acetaminophen nephrotoxicity by acetaminophen-cysteine. , 2005, Toxicology and applied pharmacology.

[67]  Steven D. Cohen,et al.  Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity II. Possible involvement of the gamma-glutamyl cycle. , 2005, Toxicology and applied pharmacology.

[68]  H. Jaeschke,et al.  Mitochondrial permeability transition in acetaminophen‐induced necrosis and apoptosis of cultured mouse hepatocytes , 2004, Hepatology.

[69]  Steven D. Cohen,et al.  Standard of care may not protect against acetaminophen-induced nephrotoxicity. , 2004, Basic & clinical pharmacology & toxicology.

[70]  B. Bailey,et al.  Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. , 2004, Annals of Emergency Medicine.

[71]  L. James,et al.  Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[72]  H. Jaeschke,et al.  Peroxynitrite Is a Critical Mediator of Acetaminophen Hepatotoxicity in Murine Livers: Protection by Glutathione , 2002, Journal of Pharmacology and Experimental Therapeutics.

[73]  E. Hazai,et al.  Reduction of toxic metabolite formation of acetaminophen. , 2002, Biochemical and biophysical research communications.

[74]  J. Hinson,et al.  Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[75]  Steven D. Cohen,et al.  Immunohistochemical localization of acetaminophen in target tissues of the CD-1 mouse: correspondence of covalent binding with toxicity. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[76]  Steven D. Cohen,et al.  Acetaminophen nephrotoxicity in CD-1 mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. , 1994, Toxicology and applied pharmacology.

[77]  A. Forbes,et al.  Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. , 1991, BMJ.

[78]  K. McMartin,et al.  4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses. , 1988, Alcoholism, clinical and experimental research.

[79]  G. Koch,et al.  Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. , 1981 .

[80]  K. McMartin,et al.  Studies on the metabolic interactions between 4-methylpyrazole and methanol using the monkey as an animal model. , 1980, Archives of biochemistry and biophysics.

[81]  J. Critchley,et al.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. , 1979, British medical journal.

[82]  K. McMartin,et al.  Pyrazoles as inhibitors of alcohol oxidation and as important tools in alcohol research: an approach to therapy against methanol poisoning. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[83]  B. Rumack,et al.  Treating acute acetaminophen poisoning with acetylcysteine. , 1977, JAMA.

[84]  K. McMartin,et al.  Methanol poisoning. I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole. , 1975, Biochemical medicine.

[85]  B. Rumack,et al.  Acetaminophen poisoning and toxicity. , 1975, Pediatrics.

[86]  S. Thorgeirsson,et al.  Acetaminophen‐induced hepatic injury: Protective role of glutathione in man and rationale for therapy , 1974, Clinical pharmacology and therapeutics.

[87]  R. Blomstrand,et al.  Inhibitory effect on ethanol oxidation in man after administration of 4-methylpyrazole. , 1970, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[88]  D. Davidson,et al.  Acute liver necrosis following overdose of paracetamol. , 1966, British medical journal.

[89]  W. Wacker,et al.  Treatment of ethylene glycol poisoning with ethyl alcohol. , 1965, JAMA.

[90]  S. Curry,et al.  Evaluation and treatment of acetaminophen toxicity. , 2019, Advances in pharmacology.

[91]  S. Doyon,et al.  Hepatotoxicity despite early administration of intravenous N-acetylcysteine for acute acetaminophen overdose. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[92]  Toshiharu Horie,et al.  Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. , 2005, Journal of hepatology.

[93]  K. Itoh,et al.  High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[94]  A. Davenport,et al.  Paracetamol (acetaminophen) poisoning resulting in acute renal failure without hepatic coma. , 1988, Nephron.

[95]  R. Garnier,et al.  4-Methylpyrazole may be an alternative to ethanol therapy for ethylene glycol intoxication in man. , 1986, Journal of toxicology. Clinical toxicology.

[96]  Ting-kai Li,et al.  Human liver alcohol dehydrogenase: inhibition by pyrazole and pyrazole analogs. , 1969, Acta chemica Scandinavica.